At the 10th SAoO Congress in Lucerne, Dr. Emilio Torres-Netto examined how advances in keratoconus care may further reduce the need for keratoplasty by 2040
ELZA’s CEO and CMO, Nikki and Farhad Hafezi flew to Hong Kong to attend APAO 2026, including an invited symposium presentation by Prof. Farhad Hafezi on Custom CXL.
Why early keratoconus screening in children is essential for preventing vision loss and long-term disability.
Cataract & Refractive Surgery Today features Prof. Farhad Hafezi on how early keratoconus management has evolved.
Swiss newspapers report on a severe contact lens–related eye infection and how an innovative treatment at ELZA Institute helped save vision.
“The eye, once thought sterile and immunoprivileged, is entangled in systemic crosstalk between microbial tenants and ocular health.”
A January 2026 The Ophthalmologist article outlines how personalised CXL is applied in three real-world scenarios: good vision, cataract planning, and markedly irregular corneas.
Dr. Dion Paridaens represented ELZA at VSOPRS Hanoi 2026, presenting expert surgical strategies for upper eyelid retraction in thyroid eye disease.
At Swiss Eye Week 2026 in Thun, Prof Farhad Hafezi contributed to ophthalmology education with lectures on corneal cross-linking and ectasia rehabilitation.
Prof Farhad Hafezi represented the ELZA Institute at Keracon 2025 in Goa, contributing invited lectures on evidence-based advances in corneal cross-linking and ectasia management.
